	US 12,460,210 B2
	Composition for regulating production of interfering ribonucleic acid
Bradley G. Thompson, Calgary (CA); and Jill L. Thompson, Calgary (CA)
Assigned to Wyvern Pharmaceuticals Inc., Calgary (CA)
Filed by Wyvern Pharmaceuticals Inc., Calgary (CA)
Filed on Oct. 31, 2024, as Appl. No. 18/933,645.
Application 18/933,645 is a division of application No. 18/518,177, filed on Nov. 22, 2023.
Prior Publication US 2025/0163435 A1, May 22, 2025
Int. Cl. C12N 15/117 (2010.01); C12N 15/86 (2006.01)

CPC C12N 15/117 (2013.01) [C12N 15/86 (2013.01); C12N 2310/141 (2013.01); C12N 2750/14143 (2013.01)]

2 Claims

1. A composition that comprises a recombinant plasmid (RP) that comprises a sequence of nucleotides that is 100% identical to the full length of SEQ ID NO: 5.